Global Market for Cold, Cough and Throat Medications to Exceed $22.2 Billion by 2015, According to New Report by Global Industry Analysts

Share Article

GIA announces the release of a comprehensive global report on Cold, Cough, and Sore Throat Remedies market. The world market for cold, cough & sore throat remedies is projected to exceed $22.2 billion by the year 2015. This is primarily driven by a rise in the population suffering from cold, cough, and sore throat symptoms, and the introduction of effective medications.

Cold, Cough & Sore Throat Remedies: A Global Strategic Business Report

Cold, cough, and sore throat are common ailments that hitch the entire northern hemisphere starting from the autumn season. The demand for cold and cough remedies increase with the onset of flu and cold during the season. School children and women under 35 years are more prone to suffer from cold and cough. Underdeveloped immune system increases the risk of exposure to cold related viruses in children who often stay in close contact with each other in a classroom. It is estimated that children are three times more susceptible to cold and cough than an average adult.

Demand for over-the-counter (OTC) cold, cough and sore throat drugs in the US is expected to surge by 2015, as stated by the new market research report on cold, cough and sore throat remedies market. In the US, common cold occurs more frequently during the fall and winter, with the majority of infections occurring between September and April. The frequency of cold incidences increases during school re-openings and winters. On an average, about one billion incidents of cold attacks are reported each year in the country. Similarly, about 17% of the population gets infected with flu virus each year. Patients with heart disease, asthma, and diabetics, pregnant women, and young children are at a higher risk of exposure to flu related complications. It is estimated that about 35000 people die each year due to flu related complications in the United States.

Key players profiled in the report include Aaron Industries, Inc., AccuMed, Inc., Bayer Corporation, Biozone Laboratories, Inc., First Boston Pharma, LLC, GlaxoSmithKline Pharmaceuticals, Limited, G.R.Lane Health Products, Limited, Johnson & Johnson, Kalbe Farma Tbk, Matrixx Initiatives, Inc., Zicam, LLC, NIZHPHARM OAO, Novartis AG, Perrigo Company, Pharmstandard Group, P. J. Noyes Company Inc, Procter & Gamble, Ranbaxy Laboratories Limited, Reckitt Benckiser Group plc, Schering-Plough Corporation, Taro Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd, and Wyeth Consumer Healthcare, among others.

The report titled "Cold, Cough & Sore Throat Remedies: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of industry overview, product overview, product introductions/innovations, profiles of major players, and recent industry activity. The study analyzes market data and analytics in terms of value sales for The United States, Canada, Japan, Europe, and Rest of World markets.

For more details about this comprehensive market research report, please visit -

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press(at)StrategyR(dot)com
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website